The Inspire ANTI SNORING Implant is a medical device that is implanted in to the body for the treatment of snoring and obstructive sleep apnea (OSA) syndrome.
ufabet Obstructive Sleep Apnea Syndrome
Obstructive sleep apnea syndrome is really a disease caused by relapsing episodes of anti snoring. This is the condition where breathing stops for more than 10 seconds, where oxygen saturation in the blood is reduced by a lot more than 4%.
OSA syndrome occurs during sleep, once the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places pressure on the body, causing increased blood pressure and development of severe diseases. The diseases due to OSA can be physical, such as for example hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during one hour of sleep and determines the severity of the disease. The apnea index is considered significant if there are a lot more than 20 apnea episodes each hour, regardless of the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many people think it is uncomfortable to sleep with the mask on the facial skin and the device itself could be loud, especially as it commonly sits near the head. Only 25% of patients can use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has come up with a very effective solution with the Inspire ANTI SNORING Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire Sleep Apnea Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of this device is placed beneath the skin, on the front right side of the chest and it monitors the phase of breathing. The other electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stick out, and helps keep the airways open while asleep.
As well as the two electrodes, this device also contains a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating during the active phase of the day, when a person needs physiological narrowing of the larynx and tongue movements for these processes.
The patient may feel light involuntary contractions of the larynx, or tongue movements during initial use of these devices. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear following the first few uses of the device.
Generally, the implant ought to be checked one or two 2 times per year. However, based on the situation, an Inspire therapy-trained doctor may consult patients more or less often.
The Inspire ANTI SNORING Implant is only suitable for:
Patients who are a lot more than 22 years old.
Patients who’ve been identified as having moderate or severe obstructive anti snoring syndrome.
Patients with an apnea index in the number of 20 to 65.
Patients who are not comfortable with using CPAP therapy or did not work.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant may potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive anti snoring syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at beginning of the treatment to 88% at 12 months and 91% at 24 months following the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the study reported a nightly usage of this therapy for five years. Therefore, it is evident that method is impressive and simple to use!